Search

Delete this article and add your own news. Morbi ac sem eget diam facilisis lobortis. Donec eu sapien maximus, sollicitudin dolor ut, semper urna. Fusce nec accumsan mauris. Integer semper, justo vitae luctus auctor, mi enim maximus sapien, eu dignissim ligula est id felis. Mauris varius arcu ex...

Dr. Trisha Pasricha and her laboratory at the BIDMC Institute for Gut-Brain Research were featured in the December Findings feature of the Harvard Gazette. The profile highlights the work examining the possibly gut-first origins of Parkinson's disease. “Parkinson’s disease is very well known and...

This review paper summarizes the genetic research contributions of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). HCHS/SOL is a landmark study that has provided crucial insights into the genetics of various health outcomes in Hispanic/Latino individuals. Due to the historically low...

BIDMC’s Hypertension Center Is the Region’s Only American Heart Association-Certified Comprehensive Care Center BOSTON - After her lifelong battle with an invisible adversary, Susan Mann and her physicians may finally have the upper hand against her treatment-resistant high blood pressure.

Dr. Secemsky, Dr. Krawisz, and Dr. Ferro presented at the 73rd Annual American College of Cardiology Scientific Session & Expo in Atlanta, Georgia. Fellows Dr. Joseph Kim and Dr. Nathan Watson also presented posters at the event.

In a nationwide observational study published this month in The Journal of the American Medical Association (JAMA), cardiologists from the Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) were commissioned by the U.S. Food and Drug Administration (FDA) to examine

Joshi, R., Brezani, V., Mey, G.M. et al. IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer’s disease. J Neuroinflammation 21, 212 (2024). https://doi.org/10.1186/s12974-024-03203-7.